In addition to the human trials, an RLL collaborator in the veterinary space has been testing AOH1996 against various forms of aggressive dog cancers.  Those cancers are very similar to human cancers. Those tests have yielded promising results as well, with the dogs all responding to various degrees to the drug. Notably, in some of the dogs, certain effects have been noted which, if they were to be replicated in humans, would be a major development in cancer treatment.